Top Abstract Purchase Related
Home
>
Node
>
Subnode

Organization of the provisional fibronectin matrix: control by products of blood coagulation

Mosher, D.F.

Thrombosis and Haemostasis 74(1): 529-533

1995

ISSN/ISBN: 0340-6245
PMID: 8578520
Document Number: 452007
Assembly of fibronectin into the provisional fibrillar matrix of embryonic tissues and wounds is a complicated process by which the intracellular cytoskeleton determines the pattern of assembly of extracellular matrix and vice versa. Assembly is restricted to dimeric fibronectin molecules with intact N-terminal modules and occurs at specialized cell surface sites. Cellular display of assembly sites is labile and requires that cells be under tension and have functional beta 1 integrins. Lysophosphatidic acid (LPA) an intermediate for de novo lipid biosynthesis and a product of platelet activation, is a powerful serum modulator of fibronectin assembly.

Document emailed within 1 workday
Secure & encrypted payments

Kharin, G.M.; Litvinov, R.I. 1988: Relation between disseminated intravascular coagulation of blood and the level of plasma fibronectin in burn shock Patologicheskaia Fiziologiia i Eksperimental'naia Terapiia 4: 41-45
Ruebsaamen, M. 1995: Liability for HIV infection by blood and blood products: A summary of the most important results of the final report of the 3rd fact-finding committee HIV infections by blood and blood products of the 12th German Bundestag AIDS-Forschung 10(6): 305-318
Rae, B.P.; Hillman, B.I.; Tartaglia, J.; Nuss, D.L. 1989: Characterization of double-stranded RNA genetic elements associated with biological control of chestnut blight: organization of terminal domains and identification of gene products EMBO Journal 8(3): 657-663
Criado, A.; Maseda, J.; Muñóz, J.A.; Reig, E.; Avello, F. 1979: Control of blood coagulation during anesthesia with etomidate Revista Espanola de Anestesiologia y Reanimacion 26(6): 562-567
Lukinmaa, P.L.; Ranta, H.; Vaheri, A. 1988: Osteogenesis imperfecta: fibronectin in dentin matrix Journal of Craniofacial Genetics and Developmental Biology 8(1): 75-82
Iarkovoĭ, E.A.; Doloman, N.I.; Ishchuk, T.A.; Ignatenko, B.I.; Trubitsyn, A.P. 1985: Organization of preventive sanitary control and elaboration of technical standards for the documentation of new technological processes, equipment, instruments, chemicals and products and their introduction to the national economy Gigiena Truda i Professional'nye Zabolevaniya (2): 7-11
Ambrus, J.L.; Courey, N.G.; Browne, B.J.; Mink, I.B.; Moore, R.H.; Ambrus, C.M. 1977: Progestational agents and blood coagulation. VIII. Effect of low-dose, alternate-day, estrogen-progestin combinations on blood coagulation factors in man, with a special note on the effect of freezing of blood samples American Journal of Obstetrics and Gynecology 128(2): 161-166
Kimata, K.; Foidart, J.M.; Pennypacker, J.P.; Kleinman, H.K.; Martin, G.R.; Hewitt, A.T. 1982: Immunofluorescence localization of fibronectin in chondrosarcoma cartilage matrix Cancer Research 42(6): 2384-2391
Langer, B.; Muraco, B.; Manasterski, J.; Bechara, M.J.; Sitrângulo Júnior, C.; Puech-Leão, L.E. 1984: Laboratory control of the effect of anti-vitamins K on blood coagulation Revista do Hospital das Clinicas 39(1): 12-17
Sviridkina, L.P.; Inchina, V.I.; Grinevskaya, Y.I. 1979: State of the blood coagulation and tissue blood coagulation factors in hypokinesia in heparinized rabbits Kosmicheskaia Biologiia i Aviakosmicheskaia Meditsina 13(4): 87-89
Gritsiuk, A.I. 1984: Disorders of blood coagulation homeostasis in the pathogenesis of intravascular blood coagulation and thrombus formation Vrachebnoe Delo 10: 56-60
Antoszczyk-Borodin, M.; Klimek, K.; Gregorczyk, J.; Chrzanowska-Ansilewska, K. 1983: Changes in the blood coagulation and fibrinolysis systems in workers in disinfection and pest control establishments Medycyna Pracy 34(4): 313-320
Wan, L.; Wu, Z.; Zhou, Y. 1996: Effect of fibronectin on the synthesis of extracellular matrix proteins in periodontal ligament cells Zhonghua Kou Qiang Yi Xue Za Zhi 31(6): 348-350
Tada, H.; Kuboki, K.; Isogai, S. 1998: Urinary fibronectin degradation products Nihon Rinsho. Japanese Journal of Clinical Medicine 56(Suppl 3): 354-359
Furcht, L.T.; Mosher, D.F.; Wendelschafer-Crabb, G.; Foidart, J.M. 1979: Reversal by glucocorticoid hormones of the loss of a fibronectin and probollagen matrix around transformed human cells Cancer Research 39(6 Pt 1): 2077-2083
Lemongello, G.J. 2007: Customized provisional abutment and provisional restoration for an immediately-placed implant Practical Procedures and Aesthetic Dentistry: Ppad 19(7): 419
Smirnov, A.V. 1991: Distribution of type I, III, IV, V collagen and fibronectin in the extracellular matrix of malignant schwannomas (immuno-morphologic study) Arkhiv Patologii 53(1): 34-39
Tripodi, A.; Arbini, A.A.; Chantarangkul, V.; Bettega, D.; Mannucci, P.M. 1993: Are capillary whole blood coagulation monitors suitable for the control of oral anticoagulant treatment by the international normalized ratio? Thrombosis and Haemostasis 70(6): 921-924
Shibata, K.; Kikkawa, F.; Nawa, A.; Thant, A.A.; Naruse, K.; Mizutani, S.; Hamaguchi, M. 1998: Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells Cancer Research 58(5): 900-903
Rodríguez Bueno, S.; Ordi Ros, J.; Vilardell Tarrés, M.; Vicente Aranguena, P.; García-Bragado Dalmau, F.; Bosch Gil, J.; Villar Casares, M.; Alijotas Reig, J. 1985: Level of plasma fibronectin in patients with hepatic cirrhosis. its relation to coagulation factor V Medicina Clinica 85(18): 746-748